VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

S. 2512 · 114th Congress

Adding Zika Virus to the FDA Priority Review Voucher Program Act

Law · 114-146 · Apr 19, 2016
Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Became law without a recorded vote. It passed by voice vote or unanimous consent, which don't record how each member voted.

AFD FrankenSponsor
11 cosponsors · 7 D, 4 R
SBD Brown JIR Isakson BND Nelson MKR Kirk BMD Menendez BCD Casey RPR Portman AKD Klobuchar PMD Murray CMD Murphy LAR Alexander

3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

  1. Senate Introduced Feb 8, 2016
  2. Senate Passed Mar 17, 2016
  3. House Passed Apr 12, 2016
  4. President To the President Apr 14, 2016
  5. President Signed Apr 19, 2016
  6. Law Apr 19, 2016

Adding Zika Virus to the FDA Priority Review Voucher Program Act

What it does: CRS summary · Public Law · Apr 19, 2016

(This measure has not been amended since it was reported to the Senate on March 15, 2016. The summary of that version is repeated here.)

Adding Zika Virus to the FDA Priority Review Voucher Program Act

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to add Zika virus disease to the list of tropical diseases under the priority review voucher program, which awards a voucher to the sponsor of a new drug or biological product that is approved to prevent or treat a tropical disease. (A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.)

The bill makes a technical correction to the tropical disease list to refer to filovirus disease, a condition caused by the family of viruses that includes the Ebola virus, instead of the family of viruses.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Adding Zika Virus to the FDA Priority Review Voucher Program Act

Latest action (Apr 19, 2016): Became Public Law No: 114-146.

Policy area: Health · Origin: Senate · Introduced: Feb 8, 2016

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

  1. Senate Introduced Feb 8, 2016
  2. Senate Passed Mar 17, 2016
  3. House Passed Apr 12, 2016
  4. President To the President Apr 14, 2016
  5. President Signed Apr 19, 2016
  6. Law Apr 19, 2016

No recorded floor vote found.